British Journal of Cancer - Table of Contents alert Volume 112 Issue 2

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 112, Issue 2 (217-412) Published online 20 January 2015 In this issue Minireviews Review Guideline Clinical Studies Translational Therapeutics Molecular Diagnostics Genetics & Genomics Also new today Advance online publication Digital Edition Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement The British Journal of Cancer presents four special Web Focuses in key areas of interest. Click on the links below to access each focus for free.  Web Focus on Systemic Inflammation as a Prognostic Marker in Cancer  Web Focus on Melanoma, the Great Leap Forward  Web Focus on New Drugs to Watch Web Focus on The Changing Landscape of Breast Cancer Prognostic Prediction   Minireviews Top Beyond BRAF: where next for melanoma therapy? I V Fedorenko, G T Gibney, V K Sondak and K S M Smalley Br J Cancer 2015 112: 217-226; advance online publication, September 2, 2014; 10.1038/bjc.2014.476 Abstract | Full Text New insights into signalling-pathway alterations in rhabdomyosarcoma B Zhu and J K Davie Br J Cancer 2015 112: 227-231; advance online publication, September 11, 2014; 10.1038/bjc.2014.471 Abstract | Full Text IRAK signalling in cancer G W Rhyasen and D T Starczynowski Br J Cancer 2015 112: 232-237; advance online publication, October 7, 2014; 10.1038/bjc.2014.513 Abstract | Full Text Review Top Imaging tumour hypoxia with positron emission tomography I N Fleming, R Manavaki, P J Blower, C West, K J Williams, A L Harris, J Domarkas, S Lord, C Baldry and F J Gilbert Br J Cancer 2015 112: 238-250; advance online publication, December 16, 2014; 10.1038/bjc.2014.610 Abstract | Full Text Guideline Top Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement G S Collins, J B Reitsma, D G Altman and K G M Moons Br J Cancer 2015 112: 251-259; advance online publication, January 6, 2015; 10.1038/bjc.2014.639 Abstract | Full Text Clinical Studies Top Phase II study of pemetrexed in combination with cisplatin in patients with advanced urothelial cancer: the PECULIAR study (KCSG 10–17) Y J Choi, S H Lee, J-L Lee, J-H Ahn, K-H Lee, D You, B Hong, J H Hong and H Ahn Br J Cancer 2015 112: 260-265; advance online publication, November 27, 2014; 10.1038/bjc.2014.591 Abstract | Full Text Pemetrexed for previously treated patients with metastatic gastric cancer: a prospective phase II study D S Zhang, Y Jin, H Y Luo, Z Q Wang, M Z Qiu, F H Wang, Y H Li and R H Xu Br J Cancer 2015 112: 266-270; advance online publication, December 4, 2014; 10.1038/bjc.2014.607 Abstract | Full Text Symptom lead times in lung and colorectal cancers: what are the benefits of symptom-based approaches to early diagnosis? M Biswas, A E Ades and W Hamilton Br J Cancer 2015 112: 271-277; advance online publication, December 2, 2014; 10.1038/bjc.2014.597 Abstract | Full Text Recurrent osteosarcoma with a single pulmonary metastasis: a multi-institutional review N C Daw, A J Chou, N Jaffe, B N Rao, C A Billups, C Rodriguez-Galindo, P A Meyers and W W Huh Br J Cancer 2015 112: 278-282; advance online publication, November 25, 2014; 10.1038/bjc.2014.585 Abstract | Full Text Prognostic factors in metaplastic carcinoma of the breast: a multi-institutional study E A Rakha, P H Tan, Z Varga, G M Tse, A M Shaaban, F Climent, C H M van Deurzen, D Purnell, D Dodwell, T Chan and I O Ellis Br J Cancer 2015 112: 283-289; advance online publication, November 25, 2014; 10.1038/bjc.2014.592 Abstract | Full Text Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN amplification R Defferrari, K Mazzocco, I M Ambros, P F Ambros, C Bedwell, K Beiske, J Bénard, A P Berbegall, N Bown, V Combaret, J Couturier, G Erminio, C Gambini, A Garaventa, N Gross, R Haupt, J Kohler, M Jeison, J Lunec, B Marques, T Martinsson, R Noguera, S Parodi, G Schleiermacher, D A Tweddle, A Valent, N Van Roy, A Vicha, E Villamon and G P Tonini Br J Cancer 2015 112: 290-295; advance online publication, November 4, 2014; 10.1038/bjc.2014.557 Abstract | Full Text QTc interval prolongation with vascular endothelial growth factor receptor tyrosine kinase inhibitors P Ghatalia, Y Je, M D Kaymakcalan, G Sonpavde and T K Choueiri Br J Cancer 2015 112: 296-305; advance online publication, November 6, 2014; 10.1038/bjc.2014.564 Abstract | Full Text Pharmacokinetics of concomitant cisplatin and paclitaxel administered by hyperthermic intraperitoneal chemotherapy to patients with peritoneal carcinomatosis from epithelial ovarian cancer L Ansaloni, F Coccolini, L Morosi, A Ballerini, M Ceresoli, G Grosso, P Bertoli, L M Busci, M Lotti, F Cambria, M Pisano, D Rossetti, L Frigerio, M D'Incalci and M Zucchetti Br J Cancer 2015 112: 306-312; advance online publication, December 2, 2014; 10.1038/bjc.2014.602 Abstract | Full Text Translational Therapeutics Top Telomere length is a novel predictive biomarker of sensitivity to anti-EGFR therapy in metastatic colorectal cancer T A Augustine, M Baig, A Sood, T Budagov, G Atzmon, J M Mariadason, S Aparo, R Maitra and S Goel Br J Cancer 2015 112: 313-318; advance online publication, November 20, 2014; 10.1038/bjc.2014.561 Abstract | Full Text The effects of CCR5 inhibition on regulatory T-cell recruitment to colorectal cancer S T Ward, K K Li, E Hepburn, C J Weston, S M Curbishley, G M Reynolds, R K Hejmadi, R Bicknell, B Eksteen, T Ismail, A Rot and D H Adams Br J Cancer 2015 112: 319-328; advance online publication, November 18, 2014; 10.1038/bjc.2014.572 Abstract | Full Text Antagonism between granulocytic maturation and deacetylase inhibitor-induced apoptosis in acute promyelocytic leukaemia cells D Hennig, S Müller, C Wichmann, S Drube, K Pietschmann, L Pelzl, M Grez, G Bug, T Heinzel and O H Krämer Br J Cancer 2015 112: 329-337; advance online publication, December 16, 2014; 10.1038/bjc.2014.589 Abstract | Full Text PARVB overexpression increases cell migration capability and defines high risk for endophytic growth and metastasis in tongue squamous cell carcinoma A Eslami, K Miyaguchi, K Mogushi, H Watanabe, N Okada, H Shibuya, H Mizushima, M Miura and H Tanaka Br J Cancer 2015 112: 338-344; advance online publication, November 25, 2014; 10.1038/bjc.2014.590 Abstract | Full Text Low FOXA1 expression predicts good response to neo-adjuvant chemotherapy resulting in good outcomes for luminal HER2-negative breast cancer cases Y Horimoto, A Arakawa, N Harada-Shoji, H Sonoue, Y Yoshida, T Himuro, F Igari, E Tokuda, O Mamat, M Tanabe, O Hino and M Saito Br J Cancer 2015 112: 345-351; advance online publication, November 25, 2014; 10.1038/bjc.2014.595 Abstract | Full Text Molecular Diagnostics Top Monitoring gastric cancer progression with circulating tumour DNA T Hamakawa, Y Kukita, Y Kurokawa, Y Miyazaki, T Takahashi, M Yamasaki, H Miyata, K Nakajima, K Taniguchi, S Takiguchi, M Mori, Y Doki and K Kato Br J Cancer 2015 112: 352-356; advance online publication, December 9, 2014; 10.1038/bjc.2014.609 Abstract | Full Text Overexpression of SMYD2 contributes to malignant outcome in gastric cancer S Komatsu, D Ichikawa, S Hirajima, H Nagata, Y Nishimura, T Kawaguchi, M Miyamae, W Okajima, T Ohashi, H Konishi, A Shiozaki, H Fujiwara, K Okamoto, H Tsuda, I Imoto, J Inazawa and E Otsuji Br J Cancer 2015 112: 357-364; advance online publication, October 16, 2014; 10.1038/bjc.2014.543 Abstract | Full Text miR-1228 promotes the proliferation and metastasis of hepatoma cells through a p53 forward feedback loop Y Zhang, J Dai, H Deng, H Wan, M Liu, J Wang, S Li, X Li and H Tang Br J Cancer 2015 112: 365-374; advance online publication, November 25, 2014; 10.1038/bjc.2014.593 Abstract | Full Text Serum sCD26 for colorectal cancer screening in family-risk individuals: comparison with faecal immunochemical test O Otero-Estévez, L De Chiara, F J Rodríguez-Berrocal, M Páez de la Cadena, J Cubiella, I Castro, C Gonzalez-Mao, V Hernandez and V S Martínez-Zorzano Br J Cancer 2015 112: 375-381; advance online publication, December 2, 2014; 10.1038/bjc.2014.605 Abstract | Full Text The tumour hypoxia marker pimonidazole reflects a transcriptional programme associated with aggressive prostate cancer H B Ragnum, L Vlatkovic, A K Lie, K Axcrona, C H Julin, K M Frikstad, K H Hole, T Seierstad and H Lyng Br J Cancer 2015 112: 382-390; advance online publication, December 2, 2014; 10.1038/bjc.2014.604 Abstract | Full Text BCAS2 promotes prostate cancer cells proliferation by enhancing AR mRNA transcription and protein stability P-C Kuo, C-W Huang, C-I Lee, H-W Chang, S-W Hsieh, Y-P Chung, M-S Lee, C-S Huang, L-P Tsao, Y-P Tsao and S-L Chen Br J Cancer 2015 112: 391-402; advance online publication, December 2, 2014; 10.1038/bjc.2014.603 Abstract | Full Text Genetics & Genomics Top B-RAF mutation and accumulated gene methylation in aberrant crypt foci (ACF), sessile serrated adenoma/polyp (SSA/P) and cancer in SSA/P A Inoue, K Okamoto, Y Fujino, T Nakagawa, N Muguruma, K Sannomiya, Y Mitsui, T Takaoka, S Kitamura, H Miyamoto, T Okahisa, T Fujimori, I Imoto and T Takayama Br J Cancer 2015 112: 403-412; advance online publication, October 14, 2014; 10.1038/bjc.2014.545 Abstract | Full Text Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.